Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)
CUSIP: 05280R100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
- Shares outstanding
- 265,957,447
- Total 13F shares
- 178,602,235
- Share change
- +533,290
- Total reported value
- $648,320,594
- Put/Call ratio
- 479%
- Price per share
- $3.63
- Number of holders
- 97
- Value change
- +$2,536,180
- Number of buys
- 36
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05280R100:
Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Syncona Portfolio Ltd |
13F
|
Company |
8%
|
21,346,829
|
$74,286,965 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
7.7%
|
20,485,611
|
$71,289,926 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.7%
|
17,889,834
|
$62,256,622 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
5.7%
|
15,272,172
|
$53,147,159 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.6%
|
12,345,678
|
$42,962,959 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
4.6%
|
12,295,167
|
$42,787,181 | — | 30 Jun 2024 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
3%
|
8,000,000
|
$27,840,000 | — | 30 Jun 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.3%
|
6,250,000
|
$21,750,000 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.7%
|
4,623,324
|
$16,089,168 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.7%
|
4,436,102
|
$15,437,635 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
4,414,087
|
$15,362,000 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.6%
|
4,300,000
|
$14,964,000 | — | 30 Jun 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
1.4%
|
3,646,230
|
$12,688,881 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.4%
|
3,639,000
|
$12,663,720 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.3%
|
3,441,667
|
$11,977,001 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
3,200,000
|
$11,136,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
2,904,843
|
$10,108,854 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1%
|
2,662,732
|
$9,266,307 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.95%
|
2,531,688
|
$8,810,276 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.92%
|
2,452,040
|
$8,533,099 | — | 30 Jun 2024 | |
| Perpetual Ltd |
13F
|
Company |
0.9%
|
2,400,412
|
$8,353,434 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.45%
|
1,188,493
|
$4,135,956 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.44%
|
1,178,723
|
$4,101,956 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.43%
|
1,145,056
|
$3,984,795 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.39%
|
1,032,988
|
$3,594,798 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
1,005,916
|
$3,500,588 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.32%
|
839,472
|
$2,921,363 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.31%
|
813,031
|
$2,829,348 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.3%
|
802,081
|
$2,791,242 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.28%
|
757,535
|
$2,636,221 | — | 30 Jun 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.26%
|
698,262
|
$2,429,952 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
668,349
|
$2,325,855 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.23%
|
610,902
|
$2,125,939 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
596,143
|
$2,074,578 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
582,865
|
$2,028,370 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
525,788
|
$1,829,742 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
523,700
|
$1,822,476 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.2%
|
518,820
|
$1,805,494 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.14%
|
380,306
|
$1,323,465 | — | 30 Jun 2024 | |
| LGT CAPITAL PARTNERS LTD. |
13F
|
Company |
0.14%
|
370,000
|
$1,287,600 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.13%
|
346,667
|
$1,206,401 | — | 30 Jun 2024 | |
| MAI Capital Management |
13F
|
Company |
0.13%
|
334,000
|
$1,162,320 | — | 30 Jun 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
266,692
|
$928,088 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.1%
|
256,700
|
$893,316 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
253,493
|
$882,156 | — | 30 Jun 2024 | |
| Atle Fund Management AB |
13F
|
Company |
0.09%
|
226,145
|
$786,984 | — | 30 Jun 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.08%
|
212,294
|
$738,783 | — | 30 Jun 2024 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.08%
|
207,097
|
$720,698 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
207,048
|
$720,527 | — | 30 Jun 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.07%
|
189,240
|
$659,000 | — | 30 Jun 2024 |
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q3 2024
As of 30 Sep 2024,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
178,602,235 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Blackstone Inc., Syncona Portfolio Ltd, FMR LLC, Deep Track Capital, LP, Avoro Capital Advisors LLC, TFG Asset Management GP Ltd, ARMISTICE CAPITAL, LLC, Frazier Life Sciences Management, L.P., and Affinity Asset Advisors, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
106
Q3 2024 holders
97
Holder diff
-9
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.